The companies that understand their specific exposure now, at the category and SKU level, are the ones with time to reposition before the pressure becomes visible in the income statement
Noom also introduced Glucose Forecasting in November 2025, which predicts the glucose impact of meals without requiring CGM hardware, available to enterprise and select consumer members
I had heard about it from a friend, and was skeptical, but I'm so glad I started coming here
The 12mg dose produced average weight loss of approximately 71.2 lbs (32.3 kg) over 68 weeks, with retatrutide 9mg reducing WOMAC knee pain scores by up to 75.8%
John Salerno for a GLP-1 Therapy Consultation in Manhattan NY and Connecticut If you are struggling with type 2 diabetes or seeking effective weight management solutions, exploring GLP-1 therapy with Dr
Instead of relying on traditional weight-loss protocols, Noom uses GLP-1 microdoses at just 25% of the standard starting dose to target key markers of metabolic function